Kimberly-Clark/$KMB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kimberly-Clark
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Ticker
$KMB
Sector
Primary listing
Employees
38,000
Headquarters
Website
Kimberly-Clark Metrics
BasicAdvanced
$40B
16.53
$7.26
0.33
$5.00
4.20%
Price and volume
Market cap
$40B
Beta
0.33
52-week high
$150.45
52-week low
$118.18
Average daily volume
2.3M
Dividend rate
$5.00
Financial strength
Current ratio
0.775
Quick ratio
0.368
Long term debt to equity
463.792
Total debt to equity
518.746
Dividend payout ratio (TTM)
67.61%
Interest coverage (TTM)
12.55%
Profitability
EBITDA (TTM)
3,827
Gross margin (TTM)
36.23%
Net profit margin (TTM)
12.32%
Operating margin (TTM)
16.68%
Effective tax rate (TTM)
19.64%
Revenue per employee (TTM)
$520,000
Management effectiveness
Return on assets (TTM)
11.09%
Return on equity (TTM)
184.20%
Valuation
Price to earnings (TTM)
16.529
Price to revenue (TTM)
2.028
Price to book
31.35
Price to tangible book (TTM)
-61.68
Price to free cash flow (TTM)
19.021
Free cash flow yield (TTM)
5.26%
Free cash flow per share (TTM)
6.311
Dividend yield (TTM)
4.16%
Forward dividend yield
4.20%
Growth
Revenue change (TTM)
5.68%
Earnings per share change (TTM)
7.38%
3-year revenue growth (CAGR)
-0.69%
10-year revenue growth (CAGR)
0.26%
3-year earnings per share growth (CAGR)
11.29%
10-year earnings per share growth (CAGR)
15.42%
3-year dividend per share growth (CAGR)
2.54%
10-year dividend per share growth (CAGR)
3.73%
What the Analysts think about Kimberly-Clark
Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.
Bulls say / Bears say
Second-quarter organic sales rose 3.9%, driven by a 5% increase in volume—its strongest volume growth in five years—highlighting the effectiveness of its revenue growth management strategy (Reuters).
Following Q2 performance, the company raised its 2025 profit forecast to low- to mid-single-digit adjusted EPS growth, reflecting confidence in sustained volume-led momentum and streamlined operations (Reuters).
In June 2025, Kimberly-Clark agreed to sell a 51% stake in its international tissue unit to Suzano for $3.4 billion, unlocking $1.73 billion in cash to refocus on higher-margin personal care and North American tissue segments (Reuters).
Q2 net sales from continuing operations fell 1.6% year-over-year to $4.16 billion, weighed by a 4.4% impact from the divestiture of its PPE business and a 1.0% foreign currency headwind (Reuters).
The company anticipates approximately $170 million in incremental tariff-related costs for 2025, exposing margins to further geopolitical trade risks despite recent reductions (Reuters).
In April 2025, Kimberly-Clark cut its full-year 2025 profit forecast to flat-to-positive adjusted EPS growth, down from prior mid-to-high single-digit expectations, citing rising supply chain costs and tariff pressures (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2025.
Kimberly-Clark Financial Performance
Revenues and expenses
Kimberly-Clark Earnings Performance
Company profitability
Kimberly-Clark News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kimberly-Clark stock?
Kimberly-Clark (KMB) has a market cap of $40B as of October 23, 2025.
What is the P/E ratio for Kimberly-Clark stock?
The price to earnings (P/E) ratio for Kimberly-Clark (KMB) stock is 16.53 as of October 23, 2025.
Does Kimberly-Clark stock pay dividends?
Yes, the Kimberly-Clark (KMB) stock pays dividends to shareholders. As of October 23, 2025, the dividend rate is $5 and the yield is 4.2%. Kimberly-Clark has a payout ratio of 67.61% on a trailing twelve-month basis.
When is the next Kimberly-Clark dividend payment date?
The next Kimberly-Clark (KMB) dividend payment date is unconfirmed.
What is the beta indicator for Kimberly-Clark?
Kimberly-Clark (KMB) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.